Sign in

CIK 0001837607

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

AEON Biopharma, Inc.

Sign in to watch
Ticker
AEON
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
853940478
Phone
+1 949-354-6499
Business address
130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
Former names
Priveterra Acquisition Corp.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Director bought 60,000 shares at $0.49 ($29,250)
  5. 4 Open-market buy Director bought 110,000 shares at an average $0.50 ($55,300)
  6. 4 Grant or award President & CEO acquired 177,103 shares (grant or award)
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4/A Grant or award Director acquired 36,021 shares (grant or award)
  10. 4 Grant or award CHIEF EXECTUIVE OFFICER acquired 470,692 shares (grant or award)
  11. 4 Grant or award EXEC VP, CLO & CORP SECRETARY acquired 180,110 shares (grant or award)
  12. 4 Grant or award Director acquired 36,021 shares (grant or award)
  13. 4 Grant or award CHIEF MEDICAL OFFICER acquired 192,117 shares (grant or award)
  14. 4 Grant or award PRINCIPAL ACCOUNTING OFFICER acquired 18,010 shares (grant or award)
  15. 4 Grant or award Director acquired 36,021 shares (grant or award)
  16. 4 Grant or award Director acquired 36,021 shares (grant or award)
  17. 4 Grant or award Director acquired 36,021 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4/A Derivatives Options or other derivatives

Page 2 of 4 · 76 filings